At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Researchers are hard at work trying to develop new medical devices to help recognize seizures, but in the meantime, you can learn to spot seizures to help keep your family and friends safe.
Seizure Rx Now Approved for Kids
The US Food and Drug Administration (FDA) has expanded the approval of a seizure medication to allow it to be used in children ages 4 to 17.
Epilepsy on the Rise
The number of Americans with epilepsy appears to be on the rise, according to the Centers for Disease Control and Prevention (CDC).
Epilepsy Rx: Old Vs. New
Some older patients with a new epilepsy diagnosis may be getting older anti-epileptic drugs (AEDs), which could have more side effects and potential drug interactions than the new ones, according to a new study.
Seizure Rx May Cut Dosing in Half
Who wants to take medication twice a day when you can take it once a day?
New Epilepsy Rx Gets FDA Nod
The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.
New Guidance for Prolonged Seizure Treatment
When seizures go on for too long, they can put patients' lives at risk. And doctors now have some new guidance on how to treat patients with prolonged seizures.
Wear Purple for Epilepsy Awareness
November is National Epilepsy Awareness Month, and this year's themes are #DareTo Go the Distance and #DareTo Be Seizure Smart.
Rx Shows Promise for Epilepsy Patients
Epilepsy patients may have a new way to fight seizures. A new medication may reduce the number of seizures these patients have.
Epilepsy Rx Recalled Due to Complaints of Empty Capsules
Dayton, NJ, Aurobindo Pharma USA is voluntarily recalling lot GESB14011-A of Gabapentin Capsules, USP 300 mg 100-count bottles to the consumer level. The product lot has been found to contain some empty capsules.